This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in the Cards for Humana (HUM) Stock in Q2 Earnings?
by Zacks Equity Research
Humana's (HUM) second quarter is likely to gain traction from solid individual Medicare Advantage membership growth.
Centene (CNC) Beats Q2 Earnings Estimates, Revises Guidance
by Zacks Equity Research
Centene's (CNC) second-quarter earnings beat on revenue and membership growth. The top line improves owing to Health Insurance Marketplace business, acquisitions and expansions.
Why Dip in UnitedHealth Stock Post Q2 is a Good Entry Point
by Zacks Equity Research
Despite concerns over some parts of UnitedHealth's (UNH) Q2 earnings, its long-term growth prospects are bright.
How Will Membership Affect UnitedHealth's (UNH) Q2 Earnings?
by Zacks Equity Research
UnitedHealth (UNH) should see an increase in Public Group and International business, partially offset by lower commercial membership.
Humana (HUM) Jointly Buys Curo, Boosts Medicare Business
by Zacks Equity Research
Humana (HUM) completes its joint acquisition of Curo with WCAS to expand its Medicare Advantage business.
5 Stocks With Domestic Focus to Evade Trade War Fears
by Ritujay Ghosh
Trade war fears have been keeping markets volatile for some time now. So it makes sense to add stocks with domestic focus to your portfolio right away.
4 Reasons That Make WellCare Health Plans an Attractive Pick
by Zacks Equity Research
WellCare Health Plans (WCG) looks attractive given its promising growth prospects.
Humana (HUM) Hits 52-Week High, Is Further Upside Left?
by Zacks Equity Research
Riding high on Kindred Healthcare acquisition and a recent rating affirmation, Humana's (HUM) shares reach a 52-week high on July 6.
Centene (CNC) Hits 52 Week High: Is Further Upside Left?
by Zacks Equity Research
Shares of Centene (CNC) gain on recent deals and its robust growth should drive it further.
WCG Vs. MOH: Which Health Insurance Stock is Better Placed
by Zacks Equity Research
Wellcare and Molina are both poised to grow in a thriving health insurance industry, but one has an edge over the other.
Ensign Boosts Skilled Nursing Facility With McCall Buyout
by Zacks Equity Research
Ensign's (ENSG) acquisition of McCall reflects its strategy to expand in the growing skilled nursing market.
Humana Jointly Acquires Kindred, Expands Into Patient Care
by Zacks Equity Research
Humana (HUM) jointly acquires Kindred to expand its geographical presence.
Centene (CNC) to Tap New York Market Through Fidelis Care
by Zacks Equity Research
Centene (CNC) acquires Fidelis Care for $3.75 billion. This strategic move is likely to help expand the company's footprint across the state of New York.
4 Top Health Insurance Stocks of 1H With Room to Run in 2H
by Sapna Bagaria
Rise in membership, revenue diversification, healthy balance sheet and cost control are behind the strong performance in 1H.
Top Analyst Reports for Pfizer, BHP Billiton & Facebook
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), BHP Billiton (BHP) and Facebook (FB)
Zacks Industry Outlook Highlights: WellCare, Molina, Humana and Anthem
by Zacks Equity Research
Zacks Industry Outlook Highlights: WellCare, Molina, Humana and Anthem
Community Health Arm to Divest AllianceHealth Deaconess
by Zacks Equity Research
Community Health (CYH) subsidiary to sell AllianceHealth Deaconess hospital in Oklahoma City to INTEGRIS Health's unit.
4 Solid Reasons to Retain Anthem (ANTM) in Your Portfolio
by Zacks Equity Research
Riding high on four factors, Anthem (ANTM) holds great potential to generate high returns for investors.
Molina Healthcare Hits 52 Week High: Is Further Upside Left?
by Zacks Equity Research
Molina Healthcare's (MOH) receipt of Florida Medicaid contract and a clearer visibility on its turnaround initiatives appear to appreciate its stock price.
UnitedHealth's Ratings Upgraded by A.M. Best, Outlook Stable
by Zacks Equity Research
A.M. Best upgrades the ratings of UnitedHealth (UNH) and its subsidiaries. The outlook for the ratings remains stable.
Top Ranked Momentum Stocks to Buy for June 22nd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 22nd:
Triple-S Management (GTS) Soared to a 52-Week-High, Time to Cash Out?
by Zacks Equity Research
Triple-S Management Corporation is at a 52 week high, but can investors hope for more gains in the future? We take a look at the fundamentals for GTS for clues.
Community Health's Ratings Downgraded by Moody's
by Zacks Equity Research
Moody's downgrades the ratings of Community Health (CYH). The outlook of the company stays stable.
Trump Boosts Small Business Health Plans: 4 Insurance Picks
by Nitish Marwah
Trump's latest order to provide an alternative to the ACA would provide millions of Americans the freedom to choose their own health policies.
Humana, Walgreens Team Up to Provide Better Senior Care
by Zacks Equity Research
Humana (HUM) ties up with Walgreens to provide better primary care and other services to seniors of the Kansas City Community.